Early buyers will receive 10% customization on this report.
Protein assays are used in life science research to determine the total protein concentration. Estimation of protein concentration is necessary in protein purification, electrophoresis, cell biology, molecular biology, and research applications.
The increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for proteomics research are the major factors driving the growth of this market.
Based on the type of assay, the protein assays market is categorized into dye-binging assays, copper-ion-based assays, test strip-based assays, and other protein assays (ultraviolet absorption, phosphatases, proteases, apoptosis-related, and SAM methyltransferases assays). The dye-binding assays segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the increasing usage of dye-binding assays in disease diagnosis.
Based on product, the protein assays market is segmented into reagents, kits, and instruments & accessories. The reagents segment is expected to account for the largest share of the market, in 2017. The growth in this segment can primarily be attributed to the repeated purchases of reagents, unlike instruments that are considered a one-time investment.
Based on technology, the protein assays market is segmented into absorbance-based protein assays, colorimetric protein assays, and fluorescence-based protein assays. In 2017, the absorbance-based protein assays segment is expected to account for the largest share of this market. The growth in this segment can primarily be attributed to the growing adoption of new techniques due to their wide range of benefits, such as increased sensitivity and accuracy.
Based on application, the protein assays market is segmented into disease diagnosis, drug discovery & development, and other applications. During the forecast period, the disease diagnosis segment is expected to grow at the highest CAGR. The growth in this segment can primarily be attributed to the increase in the R&D expenditure in the life science industry.
Based on end user, the protein assays market is segmented into pharmaceutical & biotechnology companies, clinical laboratories, hospitals, academic research institutes, and other end users. The pharmaceutical & biotechnology companies segment is expected to have the fastest growth rate during the forecast period. The growth in this segment can primarily be attributed to the increasing drug development in the life science industry.
The Asian region is expected to witness the highest growth during the forecast period. The growth in this region is primarily driven by the increasing pharmaceutical and biotechnology R&D expenditure and availability of government funding for life sciences research.
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
